In an interview to CNBC-TV18, SP Tulsian of sptulsian.com shared his view on the fundamentals of the market. He also spoke about specific stocks and sectors.

Talking about Metropolis Healthcare, he said, “We were expecting the listing to be in the range of maybe about Rs 925-935, but now it is ruling at Rs 970. Maybe because of the bullish sentiment and first day of listing, the share is ruling high. You may be able to see the level of Rs 925-930 coming in the next week to 10 days where it holds the potential. However, if you have a long term time horizon, then one can look to buy at Rs 950-960 also. Otherwise, Rs 925-930 will be an ideal entry point."

Speaking about Infosys and Tata Consultancy Services (TCS), Tulsian said, “I do not think the shift is required to be made from Infosys to TCS. However, if you have a longer-term horizon and are looking at the commentary that we are seeing from the management and taking a call only on FY20, the ideal investment always remains TCS going forward.”

Disclaimer:

The views and investment tips expressed by investment experts on CNBCTV18.com are their own and not that of the website or its management. CNBCTV18.com advises users to check with certified experts before taking any investment decisions.